Immune competition experiments demonstrated that preincubation of tissue with serum of patient 3 (recognizing GluA1 subunit) did not prevent the binding of a biotinylated AMPAR serum (also recognizing the GluA1 subunit) derived from a patient with classic symptoms of AMPAR encephalitis. This evidence concerns the gene GRIA1 and viral encephalitis.